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Problem Statement
Primary colon tumors are thought to 
have differential outcomes based on 
multiple factors including right vs. left 
sided primary location, the prevalence 
of which has not yet been verified in 
the Lehigh Valley with demographic 
analysis
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Conclusions
 
•  Colon cancer has diverse pathology 
based on embryology
  −  Right colon (midgut)
  −  Left colon (hindgut
•  Express different tumor markers due 
to this; KRAS present in 68% of L and 
linked to survival
  −  KRAS reflects EGFR mutation
•  Geographic variability in colon cancer 
due to multiple variables
  −  Health disparities
  −  Gut microbiome
•  Left sided tumors nationally have 
better outcomes
•  Right sided: later, advanced, and more 
common in women
Visual Data & Results
 
•  Comprehensive review of literature 
and national data
•  Database development with strict 
inclusion criteria applied
•  5 year retrospective chart review 
(2005-2010)
•  Descriptive statistics generated
  −  Categorical (counts/percentages)
  −  Continuous (means/standard dev)
•  Compared LVHN with national data
•  At LVHN and nationally there is a 
higher prevalence of R-sided primary 
colonic malignancies
  −  However, to a lesser degree 
•  Right side=poorer outcome
•  Real-time data needed
•  Value added to patient care (shared 
decision making) with presentation of 
local demographic/survival data
•  Within the Lehigh Valley, 52% of all 
primary colon malignancies are R 
sided
  −  Nationally, 67%
  −  Known screening and microbiome 
variability possibly implicated
  −  Hypothesis driven studies needed
•  59% Stage IV right sided
  −  Less national Stage IV data
•  Study Limitations: Lack of follow-
up, did not analyze based on chemo, 
regimens changed since 2010
•  SELECT: Values based patient 
centered care can be integrated  with 
demographics in shared decision 
making
REFERENCES:
1.  Hoffman, T, Montori V, and DelMar C. “The connection between evidence 
based medicine and shared decision making.” JAMA. October 1, 2014; 
312(13): 1295-1296. Accessed: November 17, 2016.
2.  Loupakas F, Yang D, Yau L, Feng S, et al. Primary Tumor Location as a 
Prognostic Factor in Metastatic Colorectal Cancer. Journal of the National 
Cancer Institute: 2015; 107(3).
3.  Missiaglia E, Jacobs B, D’Ario G, et al. Distal and proximal colon cancer 
differ in terms of molecular, pathological, and clinical features. Annals of 
Oncology. September 16, 2014; 00:1-7.
4.  Shen H, Yang J, Yuan Y, et al. Different treatment strategies and molecular 
features between right-sided and left-sided colon cancers. World Journal 
Of Gastroenterology [serial online]. June 7, 2015;21(21):6470-6478. 
Available from: MEDLINE with Full Text, Ipswich, MA. 
5.  Weiss J, Pfau P, O’Connor E, King J, LoConte N, Kennedy G, Smith M. 
Mortality by Stage for Right-Versus Left-Sided Colon  Cancer: Analysis of 
Surveillance, Epidemiology, and End Results—Medicare Data. Journal of 
Clinical Oncology. 2011; 29:33, 4401-4409.
Figure 2. Overall and Progression Free Survival Stratified by
Right and Left Colon (Median, IQR)
Figure 3. Tumor Classification by Specific Location in Colon


























Figure 3: Tumor Classification by Specific Location in Colon 
in All Patients vs Stage IV Patients






















Lehigh Valley Health Network, Allentown, PA
Figure 1: 1230 primary colon malignancies identified from 2005-2015 with 
subsequent inclusion/exclusion criteria applied.
Figure 2: Overall and progression free survival compared by right and left side for 
all colon malignancies as well as stage IV showing that R sided malignancies have 
better outcomes.
Figure 3: Tumor classification based on location demonstrating that stage IV 
population is similar to entire population of colon malignancies proportionally.




Age (years, mean + SD) 65.2 ± 14.1
Sex (N, %)
      Male 88 (48)
      Female 96 (52)
Race (N, %)
      Caucasian 165
      Black (90)
      Asian/Islander 2 (1)
      Other/Unknown 2 (1)
 13/7
Family History (N, %)
      CRC Cancer history 29 (16)
      Non-CRC History 45 (25)
      No Fam Cancer Hx 85 (47)
      Unknown 23 (12)
Personal Cancer Hx (N, %)
      Yes 29 (16)
      No 153 (84)
ECOG Performance 
Status (N, %) 
      0 68 (37)
      1 59 (32)
      2 13 (7)
      3 4 (2)
      4 3 (2)
      Undocumented 35 (19)
Primary Tumor Size
      Right colon 101 (55)
      Left colon 71 (39)
      Overlapping/Other 10 (6)
KRAS Mutation (N, %) 40 (22)
Metastatic Data (N, %)
      Synchronous 122 (67)
      Metachronous 50 (27)
      Unknown/Unavailable 10 (6)
# of Metastases          
(mean + SD) 1.5 + 0.92




1198 full text records 
assessed for eligibility
182 studies included in qualitative synthesis
11 records excluded for non 
adenocarcinoma primary
1016 full text records excluded 
because of:
• No documented progression to 
stage IV
• Lost to follow-up after diagnosis
• Out of network follow-up
Id
en
tifi
ca
tio
n
Sc
re
en
in
g
El
ig
ib
ili
ty
In
cl
ud
ed
